Comination of imatinib mesylate (STI-571, Gleevec) and temozolomide (temodar) displays increased activity against glioma xenografts
Publication
, Conference
Rich, J; Keir, S; Sathornsumetee, S; Reardon, D; Bigner, D; Friedman, H
Published in: NEURO-ONCOLOGY
July 1, 2005
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
July 1, 2005
Volume
7
Issue
3
Start / End Page
387 / 387
Location
Edinburgh, SCOTLAND
Publisher
DUKE UNIV PRESS
Conference Name
2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rich, J., Keir, S., Sathornsumetee, S., Reardon, D., Bigner, D., & Friedman, H. (2005). Comination of imatinib mesylate (STI-571, Gleevec) and temozolomide (temodar) displays increased activity against glioma xenografts. In NEURO-ONCOLOGY (Vol. 7, pp. 387–387). Edinburgh, SCOTLAND: DUKE UNIV PRESS.
Rich, J., S. Keir, S. Sathornsumetee, D. Reardon, D. Bigner, and H. Friedman. “Comination of imatinib mesylate (STI-571, Gleevec) and temozolomide (temodar) displays increased activity against glioma xenografts.” In NEURO-ONCOLOGY, 7:387–387. DUKE UNIV PRESS, 2005.
Rich J, Keir S, Sathornsumetee S, Reardon D, Bigner D, Friedman H. Comination of imatinib mesylate (STI-571, Gleevec) and temozolomide (temodar) displays increased activity against glioma xenografts. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2005. p. 387–387.
Rich, J., et al. “Comination of imatinib mesylate (STI-571, Gleevec) and temozolomide (temodar) displays increased activity against glioma xenografts.” NEURO-ONCOLOGY, vol. 7, no. 3, DUKE UNIV PRESS, 2005, pp. 387–387.
Rich J, Keir S, Sathornsumetee S, Reardon D, Bigner D, Friedman H. Comination of imatinib mesylate (STI-571, Gleevec) and temozolomide (temodar) displays increased activity against glioma xenografts. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2005. p. 387–387.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
July 1, 2005
Volume
7
Issue
3
Start / End Page
387 / 387
Location
Edinburgh, SCOTLAND
Publisher
DUKE UNIV PRESS
Conference Name
2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences